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Impact of Anxiety and Perceived Control on In-Hospital Complications
After Acute Myocardial Infarction
Abstract
Objectives: We tested the hypothesis that perception of control moderates any relationship between anxiety
and in-hospital complications (i.e., recurrent ischemia, reinfarction, sustained ventricular tachycardia or
fibrillation, and cardiac death) in patients with acute myocardial infarction (AMI).
Background: Anxiety is common among patients with AMI, but whether it is associated with poorer
outcomes is controversial. Conflicting findings about the relationship of anxiety with cardiac morbidity and
mortality may result from failure to consider the moderating effect of perceived control.
Methods: This was a prospective examination of the association among anxiety, perceived control, and
subsequent in-hospital complications among patients (N = 536) hospitalized for AMI.
Results: Patients’ mean anxiety level was double that of the published mean norm. Patients with higher levels
of perceived control had substantially lower anxiety (p = .001). A total of 145 (27%) patients experienced one
or more in-hospital complications. Patients with higher levels of anxiety had significantly more episodes of
ventricular tachycardia, ventricular fibrillation, and reinfarction and ischemia (p < .01 for all). In a multivariate
hierarchical logistic regression model, left ventricular ejection fraction, history of myocardial infarction,
anxiety score, and the interaction of anxiety and perceived control were significant predictors of
complications.
Conclusion: Anxiety during the in-hospital phase of AMI is associated with increased risk for in-hospital
arrhythmic and ischemic complications that is independent of traditional sociodemographic and clinical risk
factors. This relationship is moderated by level of perceived control such that the combination of high anxiety
and low perceived control is associated with the highest risk of complications.
AMI = acute myocardial infarction; CHD = coronary heart disease; BSI = Brief Symptom Inventory; CAS =
Control Attitudes Scale.
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Abstract 
Objectives:  We tested the hypothesis that perception of control moderates any 
relationship between anxiety and in-hospital complications (i.e., recurrent ischemia, 
reinfarction, sustained ventricular tachycardia or fibrillation, and cardiac death) in acute 
myocardial infarction (AMI) patients. 
Background:  Anxiety is common among AMI patients, but whether it is associated 
with poorer outcomes is controversial.  Conflicting findings about the relationship of 
anxiety with cardiac morbidity and mortality may result from failure to consider the 
moderating effect of perceived control.   
Methods:  This was a prospective examination of the association between anxiety, 
perceived control, and subsequent in-hospital complications among patients (N= 536) 
hospitalized for AMI.   
Results:  Patients’ mean anxiety level was double that of the published mean 
norm.  Patients with higher levels of perceived control had substantially lower anxiety (p < 
0.01).  A total of 145 (27%) patients experienced one or more in-hospital complications 
that comprised the combined end-point.  Patients with higher levels of anxiety had 
significantly more episodes of ventricular tachycardia, ventricular fibrillation, and 
reinfarction and ischemia (p < 0.01 for all).  In a multivariate hierarchical logistic 
regression model left ventricular ejection fraction, history of previous myocardial 
infarction, anxiety score and the interaction of anxiety and perceived control were 
significant predictors of complications.   
Conclusion:  Anxiety during the in-hospital phase of AMI is associated with 
increased risk for in-hospital arrhythmic and ischemic complications that is independent of 
traditional sociodemographic and clinical risk factors.  This relationship is moderated by 
level of perceived control such that the combination of high anxiety and low perceived 
control is associated with the highest risk of complications. 
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Accumulating evidence strongly suggests that psychological and social factors 
affect morbidity and mortality among individuals with coronary heart disease (CHD).(1-5)  
In particular, depression (6-12) and lack of social support (13-16) have been shown 
convincingly to contribute to development of acute cardiac events and CHD mortality.  
Anxiety is common and levels are high in persons hospitalized with acute cardiac events 
(4,17,18), but the influence of anxiety on subsequent cardiac events and mortality, 
particularly in the acute phase of a cardiac event, has not been well characterized.(19-21)   
In a small sample, we demonstrated previously that acute myocardial infarction 
(AMI) patients with high anxiety had 4.9 times greater risk than patients with lower anxiety 
of developing recurrent ischemia, reinfarction, ventricular tachycardia or ventricular 
fibrillation during hospitalization.(17)  Others have demonstrated that anxiety is an 
independent predictor for CHD events,(22-24) and mortality months to years after AMI, 
(25,26) although some investigators have reported that anxiety is unrelated to morbidity or 
mortality.(21,27-28)  Most notably lacking in this area of research is evidence on the 
impact of anxiety in the acute (i.e., during hospitalization) stages of myocardial infarction.  
Attention to the effect of anxiety within the early hours and days after AMI could yield 
substantial early benefits as monitoring and intervention are readily available during 
hospitalization.  
 There are several possible reasons for the disparate findings seen, including 
inadequate sample size in some studies, varying conceptual and operational definitions of 
anxiety, and use of homogeneous samples within studies, which decreases statistical 
power. Another reason may be failure to consider the role of moderators of anxiety in 
these studies. That is, there may be important factors that, when present, change the 
manner in which anxiety affects outcomes.  Identification of factors that moderate any 
association between anxiety and poor outcomes is important as such factors are targets 
for intervention. 
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One potential moderating factor is perceived control.(29-31)  Perceived control is 
associated with anxiety level.(29,32,33)  In a variety of cardiac patients, including heart 
failure, AMI, and recovering myocardial infarction and cardiac bypass patients, patients 
with higher levels of perceived control compared to those with lower levels have 
substantially lower levels of anxiety and other negative emotions.(29-33)  Patients with 
higher perceived control have a better course after diagnosis of a variety of chronic and/or 
life-threatening illnesses.(32,34,35)  In addition, investigators have demonstrated that 
perceived control can be modified by simple interventions, and that increases in perceived 
control predict improved emotional state, including lower anxiety levels. (31) 
Accordingly, we tested the hypothesis that level of perceived control moderated the 
relationship between anxiety and the development of in-hospital complications in patients 
hospitalized for AMI.  To overcome limitations of previous studies, we used a large, 
heterogeneous sample. 
Methods 
The investigation was a prospective, comparative examination of the association 
between early anxiety, perceived control, and subsequent in-hospital complications. 
Patients were enrolled from the cardiac care units of 6 diverse hospitals that included 4 
large urban university medical centers and 2 large urban community hospitals in the 
United States and Australia. 
Patients 
Institutional review board approval was obtained at all sites, and all patients gave 
signed, informed consent. From January 2001 through December 2002, consecutive 
patients were identified by the cardiac care unit manager, educator, or clinical specialist 
who briefly explained the study and informed patients that a member of the research team 
would explain the study in full, obtain consent and then conduct an interview. Cardiac care 
unit patients who met the following criteria were eligible for the study: 1) diagnosis of AMI 
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confirmed by elevated cardiac enzymes and typical ECG changes; 2) pain-free and 
hemodynamically stable at the time they were approached for inclusion in the study; 3) 
free of cognitive impairment that could interfere with ability to provide informed consent 
and participate in a short interview; 5) free of noncardiac serious or life-threatening co-
morbidities such as sepsis, shock, stroke, or acute renal failure. 
Protocol and Measurement 
Sociodemographic and clinical data (Table 1) were obtained by patient interview 
and medical record review. Within 72 hours (median 28 hours) of arrival at the hospital, 
patients were interviewed regarding anxiety (36) and perceived control,(30,37) as 
described below. Questionnaires were read to them and they were provided with 
laminated sheets that contained the possible responses for each questionnaire in very 
large type to improve ease of answering.  Although patients may have been admitted with 
or had hemodynamic compromise after admission, they were pain-free and 
hemodynamically stable when interviewed.  Complications that occurred subsequent in 
time to the interview were abstracted from the medical record by registered nurses who 
were cardiac care specialists and who were extensively trained in data collection and 
interview techniques.  Data extraction included review of every page of each patients’ 
medical record to determine complications, instead of relying on physician or nurse 
documentation of the complication.  Patients with complications before the interview were 
excluded as the occurrence of complications likely increases anxiety.  Nurses collecting 
complication data were blinded to the anxiety level of the patient.  
Anxiety Measurement 
Anxiety was defined conceptually as a feeling of foreboding, dread or threat, 
elicited by a real or imagined threat.(38) The anxiety subscale of the Brief Symptom 
Inventory (BSI) was used to measure anxiety.(36)  The anxiety subscale measures state 
(as opposed to trait) anxiety and symptom refers to psychological and not physical 
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manifestations. The BSI anxiety subscale was chosen for its brevity, reliability and validity 
in medical clinical populations, and its demonstrated sensitivity to anxiety. Construct, 
convergent, discriminant, and predictive validity of the BSI have been established in a 
series of studies.  Internal consistency coefficients for the anxiety subscale are 
consistently reported to be higher than 0.80;(17,36,39) in this study, Cronbach’s alpha was 
0.87.  The anxiety subscale of the BSI has the additional advantage of not using physical 
indicators of emotional states that often over-estimate the level of mood states in patients 
with physical disease. Each item on the BSI is rated by the patient on a 5-point scale (0-4) 
of distress ranging from "not at all" to "extremely". Item scores are summed and the mean 
obtained. Thus, the possible range of scores for the anxiety scale is 0 to 4, with higher 
scores indicative of higher levels of anxiety. Norm referenced data are available for 
comparison.(36) 
In order to further validate the use of the BSI in acutely ill patients, we conducted a 
psychometric study comparing the reliability and validity of the anxiety subscale of the BSI 
with the more established Spielberger State Anxiety Index.(40)  We found that the BSI 
demonstrated equal or greater reliability and validity in AMI patients than the Spielberger 
State Anxiety Index.  Patients found the BSI less conceptually challenging than the longer 
Spielberger State Anxiety Index and thus easier to understand. 
Perceived Control Measurement 
Control was defined as the perception or belief that individual’s have a coping 
response that can positively influence adverse events or circumstances. Importantly, 
control does not need to be exerted and the belief does not need to be realistic. The 
Control Attitudes Scale (CAS),(30,37) used to measure perceived control, consists of 4 
belief statements measuring perceived control and lack of control, in the context of cardiac 
disease. Patients rate their level of agreement with the statements on the CAS using a 7-
point Likert–type scale. Responses for each item are summed to arrive at a total score, 
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which can range from 4 to 28. Instrument reliability as assessed by internal consistency 
was high, with a Cronbach's alpha of 0.89. Content, construct, and predictive validity of the 
instrument have been demonstrated.(30,31) 
Complications 
 In-hospital complications were defined as the composite endpoint of one or more 
of the following: 1) acute recurrent ischemia as evidenced by new onset chest pain with a) 
ST segment elevation on bedside ST segment monitor or 12-lead ECG, and/or b) 
hemodynamic compromise evidenced by blood pressure or pulse changes from baseline, 
and/or c) nitrates and/or intravenous pain medication given for chest pain relief; 2) 
reinfarction as evidenced by recurrent positive CK-MB that occurs after an episode of 
recurrent chest pain or hemodynamic compromise and after CK-MB or troponin levels 
have stopped rising from the initial infarct; 3) sustained ventricular tachycardia (> 15 sec) 
or any ventricular tachycardia requiring pharmacologic or electrical intervention due to 
hemodynamic compromise and/or chest pain; 4) ventricular fibrillation; or 5) in-hospital 
death. These complications were chosen because they are the complications consistent 
with the theory that increased anxiety produces enhanced sympathetic nervous system 
arousal.   
Data Analysis 
Data are presented as means ± standard deviations or frequencies and 
percentages.  To reduce the possibility that any demonstrated association between 
increased anxiety level and complications could be explained by severity of myocardial 
infarction, or differences in treatment or sociodemographics, differences in baseline 
characteristics between higher and lower anxiety patients were examined using Chi-
square for categorical variables, Student’s t-tests or Mann-Whitney U for continuous 
variables. For these analyses only, patients were split into two groups based on the 
median split of anxiety score. In all subsequent analyses, anxiety score was used in its 
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raw form.  Baseline variables upon which the groups differed were controlled in 
subsequent analyses.  Mann-Whitney U was used to compare anxiety level between high 
control and low control patients. 
 To explore the association of anxiety, the interaction between anxiety and 
perceived control, and other potential covariates with the outcome variable of 
complications we used multiple logistic regression.  The odds ratios and 95% confidence 
intervals for the occurrence of complications in relation to the baseline sociodemographic 
(i.e. age, gender), clinical (i.e. history of hypertension, diabetes or previous AMI, type of 
infarction, aspirin or beta-blocker administration in the emergency department, anxiolytic 
use during hospitalization, left ventricular ejection fraction, admission Killip classification, 
peak chest pain level), and psychological (i.e. anxiety score, perceived control) variables 
were assessed. To evaluate the prognostic importance of anxiety in relation to other 
established measures of risk, we determined the degree to which anxiety score and 
perceived control level improved a predictive model of the other significant predictors of 
complications. These predictors were entered first into the model followed by the anxiety-
control interaction term.   
Results 
A total of 540 patients were recruited for the study. Four patients failed to complete 
the anxiety assessment instrument and thus the total final sample size was 536 (Table 1). 
The only baseline sociodemographic variable that differentiated between patients in the 
low and high anxiety groups was age (Table 1). Younger patients reported higher anxiety. 
Although there were more women in the high anxiety group compared to the low anxiety 
group, this difference did not reach statistical significance. Three clinical variables differed 
between the two groups.  Patients in the high versus low anxiety group received a beta-
adrenergic blocking agent, aspirin, or anxiolytic in the emergency department more often 
than did those in the low anxiety group (Table 2). There were no differences in treatment 
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after the emergency department and during the remainder of the hospitalization between 
the two groups with the exception that more patients in the high anxiety group received an 
anxiolytic during their hospital stay. 
Anxiety and perceived control 
 The mean anxiety level of patients in this sample (0.66  0.79) was double that of 
the published mean from the norm reference group.(36)  Nineteen percent of patients 
expressed anxiety levels that were at or above those referenced for psychiatric in-
patients.(36)  The level of perceived control ranged from a low of 4 to a high of 28 (mean 
18  5). Although there are no published norms, levels below 16 reflect a low level of 
perceived control(30,37) and 41% of patients in this sample had levels lower than 16.  
Patients with higher levels of perceived control had substantially lower anxiety than those 
with lower levels of perceived control (0.48 ± 0.75 vs 0.79 ± 0.73 p < 0.01). 
Anxiety, Perceived Control and Complications. 
 A total of 145 (27%) patients experienced one or more of the in-hospital 
complications that comprised the combined end-point.  These complications included 64 
unique episodes of ventricular tachycardia, 13 cases of multiple episodes of ventricular 
tachycardia, 26 instances of ventricular fibrillation, 110 of recurrent ischemia, 12 
reinfarctions, and 7 cardiac deaths.  In bivariate analyses, patients with higher levels of 
anxiety had significantly more episodes of the combined end-point, and of the following 
individual end-points: ventricular tachycardia, ventricular fibrillation, and reinfarction or 
ischemia (Figure 1).  There were no differences in number of cardiac deaths between 
the two groups.   
We also stratified the sample by presence of ST segment elevation myocardial 
infarction and non ST segment elevation myocardial infarction, and examined the 
association between anxiety and in-hospital complications.  Patients with higher levels of 
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anxiety had more complications than those with lower levels of anxiety regardless of 
type of AMI.  A total of 31% of ST segment elevation myocardial infarction patients 
versus 23% of non ST segment elevation myocardial infarction patients had any in-
hospital complication (p = 0.01).  In-hospital complication rates for patients with ST 
segment elevation myocardial infarction were 36% for high anxiety patients versus 23% 
for low anxiety patients (p = 0.01).  Rates for patients with non ST segment elevation 
myocardial infarction were 26% for high anxiety patients versus 15% for low anxiety 
patients (p = 0.04).   
 Of the variables tested in the multivariate hierarchical logistic regression model 
(i.e. age, gender, left ventricular ejection fraction, type of myocardial infarction, peak 
chest pain level, history of hypertension, diabetes or previous AMI, admission Killip 
classification, aspirin or beta-blocker administration in the emergency department, 
anxiolytic use during hospitalization, anxiety score, and level of perceived control), left 
ventricular ejection fraction, history of previous myocardial infarction, anxiety score and 
the interaction of anxiety and perceived control were significant predictors of 
complications (Table 3).  Patients with a lower ejection fraction, a history of previous 
AMI, and a higher level of anxiety had significantly more occurrences of the combined 
end-point.  In addition, the interaction of anxiety and perceived control was a significant 
predictor of complications, indicating that perceived control moderated the relationship 
between anxiety and complications.  Patients with high anxiety and low perceived control 
had the highest occurrence of complications (Figure 2). 
   
Discussion 
 Results of this multicenter study contribute to the body of literature implicating 
anxiety as a risk factor for short- and long-term physical complications after AMI.(25,41)  
It is one of the few investigations of the impact of anxiety very early after AMI on in-
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hospital complications.  Both ischemic and arrhythmic complications were predicted by 
the presence of higher anxiety.  Importantly, this relationship was independent of the risk 
conferred by a number of traditional clinical factors.  Risk stratification after AMI 
continues to be driven by clinical variables alone.  Results from this study and from 
others demonstrating the long-term cardiovascular risks of negative affective states and 
social isolation provide further evidence that psychological and social factors should be 
considered when assessing risk after AMI and that interventions to decrease anxiety need 
to be investigated and applied widely.(5) 
 Conflicting findings to date about the relationship between anxiety and outcomes in 
CHD patients are thought primarily to be the result of two major factors: failure to consider 
moderators of anxiety and anxiety measurement ambiguities.  Our findings further the 
research regarding the role of anxiety in morbidity and mortality outcomes among those 
with heart disease by demonstrating the moderating effect of perceived control on the 
association between anxiety and in-hospital outcomes.  Patients with high levels of anxiety 
had significantly more complications than those with low anxiety, but those with the 
greatest occurrence of complications were patients with both high anxiety and low 
perceived control.   
 Perceived control is modifiable by a number of simple, but well-timed, well-
constructed, systematically delivered interventions.(31)  Such interventions include 
education and counseling to reframe an acute cardiac event from an out of control crisis to 
the herald of a chronic condition that can be controlled with adherence to recommended 
therapy and lifestyle changes.(42,43)  Given that the over-riding threat for most individuals 
after an acute cardiac event is the perception of a loss of control(44) (45) plus the strong 
inverse association between perceived control and anxiety,(29,30,33) aggressive 
development and testing of specific intervention approaches targeted at increasing the 
perception of control among AMI patients appears warranted.  
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 With regard to measurement ambiguities that may have clouded the accurate 
assessment of the relationship between anxiety and outcomes, the major controversy has 
centered around the measurement of clinical anxiety syndromes such as phobic anxiety 
versus symptoms of anxiety.  Some researchers have contended that it is only clinically 
diagnosed anxiety syndromes that are associated with morbidity and mortality outcomes.  
However, our previous work(17), the results presented in this study, and the work of others 
who have measured anxiety symptoms, but not anxiety syndromes(25,46) and 
demonstrated a strong independent association between anxiety and patient outcomes 
argues against this stance.   
 Patients in this study expressed a mean anxiety level that was 50% greater than 
the norm reference figure and almost a quarter of patients reported anxiety levels that 
exceed those reported by psychiatric in-patients.  This was despite the finding that patients 
in the higher anxiety group tended to receive an anxiolytic more often in the emergency 
department and during hospitalization.  These findings highlight the persistent problem of 
inadequate assessment and management of anxiety and other psychological problems in 
cardiac patients.(47,48)  Anxiety can not be treated unless it is first recognized.  Without a 
formal screening instrument, clinicians are not able to accurately identify psychological 
distress in their patients.(47,48)  Routine use of a short, simple anxiety assessment 
appears warranted in the hospital setting for patients suffering acute cardiac events.  A 
number of such instruments exist and have been shown to be valid for screening in clinical 
settings.(49)  The instrument used in this study assesses anxiety using 6 items and has 
been shown to perform well in a variety of clinical cardiac settings.(17,50)   
 The mechanisms whereby anxiety could be associated with morbidity and mortality 
outcomes in AMI patients remain unclear.  The major theories are that both physiological 
and behavioral mechanisms contribute to poor physical outcomes in anxious cardiac 
patients.(5)  Although behavioral mechanisms (e.g. nonadherence to medications or 
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lifestyle change recommendations, adoption or maintenance of risky behaviors such as 
smoking or sedentary life-style) likely are important factors that contribute to the 
relationship between psychological distress and physical outcomes seen on long-term 
follow-up, it is unlikely that they play a major role in precipitating acute cardiac events in 
the short-term among AMI patients.  A more plausible mechanism linking anxiety with in-
hospital complications in AMI patients is a physiologic one wherein excess activation of 
the sympathetic nervous system results in decreased heart rate variability, increased 
platelet aggregation and other changes in coagulation, alterations in fibrillation threshold, 
and endothelial dysfunction.(5)  Although we did not test mechanisms in this study, the 
increased incidence of ischemic and arrhythmic complications seen in patients with higher 
anxiety supports the theory that anxiety is associated with excess sympathetic nervous 
system activation. 
Study Limitations.  A potential limitation in this study relates to concerns about 
generalizability.  The incidence of ST segment elevation myocardial infarction was higher 
in this sample than seen in large registries of acute myocardial infarction patients, 
suggesting that this sample does not completely reflect the typical proportions of ST 
segment elevation myocardial infarction and non-ST segment elevation myocardial 
infarction.  Our higher proportion of ST segment elevation myocardial infarction is likely 
due to our inclusion criteria and the need to identify patients very early in the course of 
hospitalization.  Nonetheless, our large sample size provided a sufficient number of non 
ST segment elevation myocardial infarction patients to allow generalizability to both types 
of AMI patients. 
Conclusion. 
 Anxiety during the in-hospital phase of AMI care is associated with an increased 
risk for in-hospital arrhythmic and ischemic complications that is independent of a number 
of traditional sociodemographic and clinical risk factors.  This relationship is moderated by 
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level of perceived control such that the combination of high anxiety and low perceived 
control is associated with the highest risk.  These findings provide specific targets for 
intervention to sever the link between anxiety and poor physical outcomes in hospitalized 
AMI patients.  Assessment for anxiety in hospitalized AMI patients is warranted given the 
high levels that exist in this patient population and the potential for adverse outcomes 
associated with anxiety. 
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Figure Legends 
 
Figure 1.  Comparison of in-hospital complication rates by high and low anxiety 
groups. 
 
Figure 2.  The moderating impact of perceived control on the relationship between 
anxiety and complications.  Comparison of percentage of patients out of the entire 
sample who had complications based on anxiety and perceived control. 
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Table 1. Characteristics of the sample of 536 acute myocardial infarction patients 
 Entire Sample 
N = 536 
High Anxiety 
n = 262 
Low Anxiety 
n = 274 
Sexc 
    Male 
    Female 
 
354 (66) 
180 (34) 
 
165 (63) 
97 (37) 
 
189 (70) 
83 (30) 
Marital statusc 
    Married/cohabitate 
    Single/divorced/ widowed 
 
369 (69) 
164 (31) 
 
182 (70) 
79 (30) 
 
187 (69) 
85 (31) 
Age, yearsb,* 62  14 60  13 64  13 
Education, yearsb 13  3 13  3 13  3 
Peak chest pain, scale 0 to 10, 10 = 
worstd 
7  3 7  3 7  3 
Peak CK-MB, ng/mld 148  167 151  175 145  160 
ST segment elevation myocardial 
infarctionc 
330 (64) 162 (64) 168 (63) 
Left ventricular ejection fraction, %b 50   13 51  14 49  13 
Admission Killip classc 
 I/II 
 III/IV 
 
485 (92) 
45 (9) 
 
234 (91) 
23 (9) 
 
251 (92) 
22 (8) 
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Diabetesc 116 (22) 57 (22) 59 (22) 
Hypertensionc 301 (57) 147 (57) 154 (57) 
Previous myocardial infarctionc 144 (27) 66 (25) 78 (29) 
Admission systolic blood pressure, 
mmHgb 
141  28 141  28 142  29 
Admission diastolic blood pressure, 
mmHgb 
81  18 81  18 81  18 
Admission pulse, beats/minb 79  21 79  19 79  22 
 
Values are n (%) or mean  SD; * p < 0.05 for comparison between high and low anxiety 
groups; statistical tests used to compare high vs low anxiety patients were chi-square,c 
Student’s t-test,b or Mann-Whitney Ud 
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Table 2.  Treatments Received in the Emergency Department and Hospital (n=536) 
 
 Entire 
Sample 
N = 536 
High Anxiety 
n = 262 
Low Anxiety 
n = 274 
P* 
Fibrinolysis in ED 163 (31) 86 (34) 77 (28) .22 
Beta-adrenergic blocking agent in ED 237 (46) 126 (50) 111 (41) .04 
Aspirin in ED 421 (80)  214 (84) 207 (76) .03 
Anxiolytic in ED 168 (32) 92 (37) 76 (28) .05 
Coronary artery bypass grafting 62 (12) 23 (9) 39 (14) .06 
Angioplasty 337 (64) 166 (65) 171 (63) .65 
ACEI during hospitalization 313 (60) 146 (58) 167 (61) .38 
Beta-adrenergic blocking agent during 
hospitalization 
450 (85) 218 (84) 232 (85) .81 
As needed anxiolytic during 
hospitalization 
247 (47) 135 (53) 112 (42) .01 
* p value for comparison between high and low anxiety groups; chi-square used for 
comparisons; ACEI = Angiotensin converting enzyme inhibitor; ED = emergency 
department 
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Table 3: Multivariate Hierarchical Logistic Regression for Prediction of In-hospital 
Complications 
Predictor Odds Ratio CI P 
Previous myocardial infarction 1.9 1.1 - 3.3 <0.01 
Left ventricular ejection fraction .97 .96 - .99 <0.01 
Anxiety score 1.5 1.1 – 2.0 <0.01 
Anxiety score * perceived control 1.3 1.1 – 1.8 <0.01 
In a test of the following model: age, sex, hypertension, diabetes, previous myocardial 
infarction, left ventricular ejection fraction, type of myocardial infarction, peak pain level, 
admission Killip class, aspirin administration in the emergency department, beta-blocker 
administration in the emergency department, anxiolytic given during hospitalization, total 
anxiety score, perceived control and the interaction of anxiety score and perceived 
control 
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Figure 1. 
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Figure 2. 
 
 
